Cited by 105Treatment of Major DepressionTryptophan and brain disordersStress Responses and Cortisol

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients

Open access

Stelzhammer, Viktoria, Haenisch, Frieder, Chan, Man K., Cooper, Jason D., Steiner, Johann, Steeb, Hannah, Martins-de-Souza, Daniel, Rahmoune, Hassan, Guest, Paul C., Bahn, Sabine·2014·The International Journal of Neuropsychopharmacology

DOI 10.1017/s1461145714000819

Open this paper in CoChat — free account Open PDF

Abstract

Major depressive disorder (MDD) is a complex and multi-factorial disorder. Although genetic factors and other molecular aspects of MDD have been widely studied, the underlying pathological mechanisms are still mostly unknown. We sought to investigate the pathophysiology of MDD by identifying and characterising serum molecular differences and their correlation to symptom severity in first onset, antidepressant drug-naïve MDD patients. We performed an exploratory molecular profiling study on serum samples of MDD patients and controls using multiplex immunoassay and label-free liquid chromatography mass spectrometry in data independent mode (LC-MSE). We included two independent cohorts of first onset, antidepressant drug-naïve MDD patients (n = 23 and 15) and matched controls (n = 42 and 21) in our study in order to validate the results. The main outcome included the following list of circulatory molecules changing and/or correlating to symptom severity: angiotensin-converting enzyme, acute phase proteins (e.g. ferritin and serotransferrin), brain-derived neurotrophic factor, complement component C4-B, cortisol, cytokines (e.g. macrophage migration inhibitory factor and interleukin-16), extracellular newly identified receptor for advanced glycosylation end products-binding protein, growth hormone and superoxide dismutase-1. This study provides evidence of an increased pro-inflammatory and oxidative stress response, followed by a hyperactivation of the HPA-axis in the acute stages of first onset MDD, as well as a dysregulation in growth factor pathways. These findings help to elucidate MDD related pathways in more detail and further studies may lead to identification of novel drug targets, including components of the inflammatory and oxidative stress response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1017/s1461145714000819

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature reviews. Immunology · doi:10.1038/nri1200 · Cited by 1,782
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Major Depressive Disorder
D, M. F. M., & Kendler, K. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00112-4 · Cited by 654
Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures
Li, G., Vissers, J. P. C., Silva, J. C., Golick, D., Gorenstein, M. V., & Geromanos, S. J. (2009) · PROTEOMICS · doi:10.1002/pmic.200800564 · Cited by 556

Show all 45 references

Research works printed but not linked: 5

2013, Biochim Biophys Acta, 1836, 245
2010, Curr Opin Investig Drugs, 11, 31
2007, Actas Esp Psiquiatr, 35, 249
2009, Psychiatry (Edgmont), 6, 18
2010, Biomark Insights, 5, 39

Sorted by citations

Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
Nutritional Aspects of Depression
Lang, U. E., Beglinger, C., Schweinfurth, N., Walter, M., & Borgwardt, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430229 · Cited by 255
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
Gadad, B. S., Jha, M. K., Czysz, A., Furman, J. L., Mayes, T. L., Emslie, M. P., & Trivedi, M. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.001 · Cited by 205
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
Davidson, M., Rashidi, N., Nurgali, K., & Apostolopoulos, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179968 · Cited by 182
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis
Cattaneo, A., Macchi, F., Plazzotta, G., Veronica, B., Bocchio-Chiavetto, L., Riva, M. A., & Pariante, C. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00040 · Cited by 152
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank: Figure 1.
Scarr, E., Millan, M. J., Bahn, S., Bertolino, A., Turck, C. W., Kapur, S., Möller, H., & Dean, B. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv042 · Cited by 135
Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future
Comes, A. L., Papiol, S., Müeller, T., Geyer, P. E., Mann, M., & Schulze, T. G. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0219-2 · Cited by 107
Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Perrin, A. J., Horowitz, M. A., Roelofs, J., Zunszain, P. A., & Pariante, C. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00423 · Cited by 98
Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages
Tayeb, A. E. K. A., Poinsignon, V., Chappell, K., Bouligand, J., Becquemont, L., & Verstuyft, C. (2023) · Antioxidants · doi:10.3390/antiox12040942 · Cited by 100
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders
Frye, M. A., Nassan, M. M., Jenkins, G. D., Kung, S., Veldić, M., Palmer, B. A., Feeder, S. E., Tye, S. J., Choi, D., & Biernacka, J. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.185 · Cited by 89
The role of macrophages in anti-inflammatory activity of antidepressant drugs
Nazimek, K., Strobel, S. D., Bryniarski, P., Kozlowski, M., Filipczak-Bryniarska, I., & Bryniarski, K. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.07.001 · Cited by 91
Serum proteomic profiles of depressive subtypes
Lamers, F., Bot, M., Jansen, R., Chan, M. K., Cooper, J. D., Bahn, S., & Penninx, B. W. J. H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.115 · Cited by 89
Biomarkers for Depression: Recent Insights, Current Challenges and Future Prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16206 · Cited by 76
Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies
Mendes‐Silva, A. P., Pereira, K. S., Araújo, G. T. T., Nicolau, E. D. S., Silva-Ferreira, C. M., Teixeira, A. L., & Diniz, B. S. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.07.017 · Cited by 76
Discovery of serum protein biomarkers in drug-free patients with major depressive disorder
Lee, M. Y., Kim, E. Y., Kim, S. H., Cho, K.-C., Ha, K., Kim, K. P., & Ahn, Y. M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.009 · Cited by 75
Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype
Diniz, B. S., Reynolds, C. F., Sibille, E., Lin, C.-W., Tseng, G., Lotrich, F., Aizenstein, H. J., & Butters, M. A. (2017) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.08.018 · Cited by 73
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Young, J. J., Silber, T., Bruno, D., Galatzer‐Levy, I. R., Pomara, N., & Marmar, C. R. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00072 · Cited by 73
Advances in Biomarkers of Major Depressive Disorder
Huang, T., & Lin, C.-C. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2014.11.003 · Cited by 71
Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis
Heurich, M., Föcking, M., Mongan, D., Cagney, G., & Cotter, D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01197-9 · Cited by 68
Inflammatory cytokines, complement factor H and anhedonia in drug-naïve major depressive disorder
Tang, W., Liu, H., Chen, L., Zhao, K., Zhang, Y., Zheng, K., Zhu, C., Zheng, T., Liu, J., Wang, D., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.03.022 · Cited by 53
Circulating biosignatures of late-life depression (LLD): Towards a comprehensive, data-driven approach to understanding LLD pathophysiology
Diniz, B. S., Lin, C., Sibille, E. L., Tseng, G. C., Lotrich, F. E., Aizenstein, H. J., Reynolds, C. F., & Butters, M. A. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.006 · Cited by 50
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry
Lozupone, M., Seripa, D., Stella, E., Montagna, M. L., Solfrizzi, V., Quaranta, N. A. A., Veneziani, F., Cester, A., Sardone, R., Bonfiglio, C., et al. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1375857 · Cited by 52
iTRAQ technology-based identification of human peripheral serum proteins associated with depression
Wang, Q., Su, X., Jiang, X., Dong, X., Fan, Y., Zhang, J., Yu, C., Gao, W., Shi, S., Jiang, J., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.055 · Cited by 49
Sirukumab: A Potential Treatment for Mood Disorders?
Zhou, A. J., Lee, Y. L., Salvadore, G., Hsu, B. L., Fonseka, T. M., Kennedy, S. H., & McIntyre, R. S. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0455-x · Cited by 50
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45
Identifying Plasma Biomarkers with high specificity for major depressive disorder: A multi-level proteomics study
Shi, Y., Song, R., Wang, L., Qi, Y., Zhang, H., Zhu, J., Zhang, X., Tang, X., Zhan, Q., Zhao, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.078 · Cited by 49
Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies
Mongan, D., Sabherwal, S., Susai, S. R., Föcking, M., Cannon, M. D., & Cotter, D. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.036 · Cited by 47
Depression in breast cancer patients: Immunopathogenesis and immunotherapy
Yu, S., Li, W., Tang, L., Fan, X., Yao, S., Zhang, X., Bi, Z., & Cheng, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215648 · Cited by 51
Diagnosis of major depressive disorder by combining multimodal information from heart rate dynamics and serum proteomics using machine-learning algorithm
Kim, E. Y., Lee, M. Y., Kim, S. H., Ha, K., Kim, K. P., & Ahn, Y. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.014 · Cited by 47
Blood biomarker discovery in drug-free schizophrenia: the contribution of proteomics and multiplex immunoassays
Sabherwal, S., English, J. A., Föcking, M., Cagney, G., & Cotter, D. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1252262 · Cited by 40
Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor
Hasebe, K., Gray, L. J., Bortolasci, C. C., Panizzutti, B., Mohebbi, M., Kidnapillai, S., Spolding, B., Walder, K. R., Berk, M., Malhi, G. S., et al. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.2 · Cited by 37
The Emergence of Point-Of-Care Blood-Based Biomarker Testing for Psychiatric Disorders: Enabling Personalized Medicine
Guest, F. L., Guest, P. C., & Martins‐de‐Souza, D. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2015-0055 · Cited by 36
Blood-based immune-endocrine biomarkers of treatment response in depression
Chan, M. K., Cooper, J. D., Bot, M., Birkenhäger, T. K., Bergink, V., Drexhage, H. A., Steiner, J. H., Rothermundt, M., Penninx, B. W. J. H., & Bahn, S. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.08.020 · Cited by 36
Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders
Preece, R. L., Han, S. Y. S., & Bahn, S. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1444483 · Cited by 38
Salivary proteomics and biomarkers in neurology and psychiatry
Wormwood, K. L., Aslebagh, R., Channaveerappa, D., Dupree, E. J., Borland, M. M., Ryan, J. P., Darie, C. C., & Woods, A. G. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400153 · Cited by 36
Inflammatory markers in persons with clinically-significant depression, anxiety or PTSD: A systematic review and meta-analysis
Kuring, J. K., Mathias, J. L., Ward, L., & Tachas, G. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.10.009 · Cited by 39
Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease
Rocha, N. P., Scalzo, P. L., Barbosa, I. G., de Campos-Carli, S. M., Tavares, L. D., de Souza, M. S., Christo, P. P., Reis, H. J., Silva, A. C. S. E., & Teixeira, A. L. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.07.031 · Cited by 33
Plasma complement component 4 increases in patients with major depressive disorder
Wei, J., Liu, Y., Zhao, L., Yang, X., Ni, P., Wang, Y., Li, T., & Ma, X. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s151238 · Cited by 31
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial
Gadad, B. S., Jha, M. K., Grannemann, B. D., Mayes, T. L., & Trivedi, M. H. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.05.012 · Cited by 30
Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response
Turck, C. W., Guest, P. C., Maccarrone, G., Ising, M., Kloiber, S. M., Lucae, S., Holsboer, F., & Martins‐de‐Souza, D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00272 · Cited by 29
Quantitative Proteomic Analysis Reveals Synaptic Dysfunction in the Amygdala of Rats Susceptible to Chronic Mild Stress
Zhou, M., Liu, Z., Yu, J. H., Li, S., Tang, M., Zeng, L., Wang, H., Xie, H., Peng, L., Huang, H., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.010 · Cited by 28
Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders—Longitudinal Study in Adolescent and Young Adult Patients
Skibińska, M., Kapelski, P., Dmitrzak‐Węglarz, M., Lepczyńska, N., Pawlak, J., Hauser, J., Szczepankiewicz, A., & Rajewska‐Rager, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184064 · Cited by 28
Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study
Ryan, K. M., Glaviano, A., O'Donovan, S. M., Kolshus, E., Dunne, R. A., Kavanagh, A., Jelovac, A., Noone, M., Tucker, G., Dunn, M. J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.51 · Cited by 26
Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles
Chan, M. K., Cooper, J. D., & Bahn, S. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.09.010 · Cited by 28
Molecular serum signature of treatment resistant depression
Ruland, T., Chan, M. K., Stocki, P., Grosse, L., Rothermundt, M., Cooper, J. D., Arolt, V., & Bahn, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4348-0 · Cited by 26
Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography–tandem mass spectrometry
Kim, H.-Y., Rhee, S. J., Lee, H., Han, D., Lee, T. Y., Kim, M., Kim, E. Y., Kwon, J. S., Shin, H., Kim, H., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113850 · Cited by 25
Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma
Luo, X., Fang, Z., Lin, L., Xu, H., Huang, Q., & Zhang, H. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04410-3 · Cited by 28
Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
Sharma, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160106155331 · Cited by 24
An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks
Kim, E. Y., Ahn, H., Lee, M. Y., Yu, J., Yeom, J., Jeong, H., Min, H., Lee, H. J., Kim, K., & Ahn, Y. M. (2020) · Biomedicines · doi:10.3390/biomedicines8110455 · Cited by 23
Inhibitory effects of fluoxetine on the secretion of inflammatory mediators and JAK/STAT3 and JNK/TLR4 gene expression
Mojiri-Forushani, H., Khajehali, E., Adelipour, M., & Mohammadi, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08219-x · Cited by 24
Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology
Ziani, P. R., Feiten, J. G., Goularte, J. F., Colombo, R., Antqueviezc, B., Géa, L. P., & Rosa, A. R. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.2.211 · Cited by 25
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders
Levchenko, А., Nurgaliev, T., Kanapin, A. A., Samsonova, A. A., & Gainetdinov, R. R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03990 · Cited by 20
Fluoxetine ameliorates depressive symptoms by regulating lncRNA expression in the mouse hippocampus
Zhang, C.-L., 昆明650201，中国, 中., State Key Laboratory of Phytochemistry and Plant Resources in West China, Y. K. L. O. N. M. C., Li, Y.-J., Lu, S., Zhang, T., Xiao, R., Luo, H.-R., 呼和浩特010110，中国, 内., 中国科学院大学，北京100049，中国, et al. (2021) · Zoological Research · doi:10.24272/j.issn.2095-8137.2020.294 · Cited by 20
Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder
Rodrigues, J. E., Martinho, A., Santos, V., Santa, C., Madeira, N. G. G. F., Martins, M. J., Pato, C. N., Macedo, A., & Manadas, B. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105460 · Cited by 21
Plasma proteomics reveals coagulation, inflammation, and metabolic shifts in H-type hypertension patients with and without acute ischemic stroke
Zhou, F., Zhou, L., Guo, T., Wang, N., Hao, H., Zhou, Y., & Yu, D. (2017) · Oncotarget · doi:10.18632/oncotarget.22233 · Cited by 20
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals
Han, S. Y. S., Cooper, J. D., Özcan, S., Rustogi, N., Penninx, B. W. J. H., & Bahn, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0623-2 · Cited by 20
Associations between SNPs and immune-related circulating proteins in schizophrenia
Chan, M. K., Cooper, J. D., Heilmann‐Heimbach, S., Frank, J., Witt, S. H., Nöthen, M. M., Steiner, J. H., Rietschel, M., & Bahn, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12986-0 · Cited by 19
Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry
Shin, D., Rhee, S. J., Lee, J., Yeo, I., Do, M., Joo, E.-J., Jung, H. Y., Roh, S., Lee, S., Kim, H.-Y., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00058 · Cited by 20
Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood
Han, S. Y. S., Tomasik, J., Rustogi, N., Lago, S. G., Barton‐Owen, G., Eljasz, P., Cooper, J. D., Özcan, S., Olmert, T., Farrag, L. P., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.08.011 · Cited by 18
Point-of-Care Testing and Personalized Medicine for Metabolic Disorders
Guest, F. L., & Guest, P. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7614-0_6 · Cited by 16
Changes in cortical protein markers of iron transport with gender, major depressive disorder and suicide
Dean, B., Tsatsanis, A., Lam, L. Q., Scarr, E., & Duce, J. A. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1555377 · Cited by 16
Machine learning models of plasma proteomic data predict mood in chronic stroke and tie it to aberrant peripheral immune responses
Bidoki, N. H., Zera, K. A., Nassar, H., Drag, L. L., Mlynash, M., Osborn, E., Musabbir, M., Kim, D. E., Mendez, M. P., Lansberg, M. G., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.002 · Cited by 16
Neuropeptidome of the Hypothalamus and Pituitary Gland of Indicine × Taurine Heifers: Evidence of Differential Neuropeptide Processing in the Pituitary Gland before and after Puberty
DeAtley, K. L., Colgrave, M. L., Cánovas, Á., Wijffels, G. L., Ashley, R. L., Silver, G. A., Rincón, G., Medrano, J. F. F., Islas‐Trejo, A., Fortes, M. R. S., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00875 · Cited by 15
Proteomic Markers for Depression
Silva-Costa, L. C., Carlson, P. T., Guest, P. C., de Almeida, V., & Martins‐de‐Souza, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_10 · Cited by 16
RAGE Signaling pathway in hippocampus dentate gyrus involved in GLT-1 decrease induced by chronic unpredictable stress in rats
Yang, F., Wang, H., Chen, H., Ran, D., Tang, Q., Weng, P., Sun, Y., & Jiang, W. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.06.020 · Cited by 14
Can Molecular Biology Propose Reliable Biomarkers for Diagnosing Major Depression?
Ivanets, N. N., Svistunov, A. А., Chubarev, V. N., Kinkulkina, M. A., Tikhonova, Y. G., Syzrantsev, N. S., Sologova, S. S., Ignatyeva, N. V., Mutig, K., & Tarasov, V. V. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201124110437 · Cited by 17
Decreased Plasma Levels of Angiotensin-Converting Enzyme Among Patients With Bipolar Disorder
Sanches, M., Colpo, G. D., Cuellar, V. A., Bockmann, T., Rogith, D., Soares, J. C., & Teixeira, A. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.617888 · Cited by 14
Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study
Tunç, S., Atagün, M. İ., Başbuğ, H. S., & Erel, Ö. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1584489 · Cited by 14
Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical Approach
Chan, M. K., Cooper, J. D., Bot, M., Steiner, J. H., Penninx, B. W. J. H., & Bahn, S. (2015) · Neuroendocrinology · doi:10.1159/000442208 · Cited by 14
Neuropsychiatric disorders: An immunological perspective
Aw, E., Zhang, Y., Yalçın, E., Herrmann, U., & Carroll, M. C. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.002 · Cited by 13
Epigenome-wide DNA methylation in unipolar depression: predictive biomarker of antidepressant treatment response?
Schiele, M. A., Crespo Salvador, O., Lipovsek, J., Schwarte, K., Schlosser, P., Zwanzger, P., Arolt, V., Baune, B. T., Köttgen, A., & Domschke, K. (2024) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae045 · Cited by 13
Enzymatic biomarkers of oxidative stress in patients with depressive disorders. A systematic review
Lievanos-Ruiz, F. J., & Fenton-Navarro, B. (2024) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2024.110788 · Cited by 14
Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders
del Valle, E., Rubio-Sardón, N., Menéndez-Pérez, C., Martínez‐Pinilla, E., & Navarro, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115631 · Cited by 12
Association study of MIF promoter polymorphisms with suicide completers in the Japanese population
Shimmyo, N., Hishimoto, A., Otsuka, I., Okazaki, S., Boku, S., Mouri, K., Horai, T., Takahashi, M., Ueno, Y., Shirakawa, O., et al. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s130855 · Cited by 11
The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression
Carboni, L. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400139 · Cited by 10
Ferritin disorder in the plasma and hippocampus associated with major depressive disorder
Wang, Y., Li, Y., Wu, Z., Chen, Z., Yu, H., He, Y., Tian, Y., Lan, T., Bai, M., Chen, X., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.059 · Cited by 11
Neuroproteomic profiling of human body fluids
Månberg, A., Schwenk, J. M., & Nilsson, P. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500065 · Cited by 11
Aldosterone Action on Brain and Behavior
Murck, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00052-3 · Cited by 10
Association between suicide attempts and anemia in late-life depression inpatients
Li, J., Wang, L., Wang, Z., Zhao, F., Sun, Y., Lu, Y., & Yang, L. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04649-9 · Cited by 9
A Complete Proteomic Workflow to Study Brain-Related Disorders via Postmortem Tissue
Reis‐de‐Oliveira, G., Fioramonte, M., & Martins‐de‐Souza, D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8994-2_31 · Cited by 9
Depression Augments Plasma APOA4 without Changes of Plasma Lipids and Glucose in Female Adolescents Carrying G Allele of APOA4 rs5104
Guo, Q., Si, Y. J., Shen, Y. L., Chen, X., Yang, M., Fang, D. Z., & Lin, J. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01766-7 · Cited by 8
Iron metabolism dysfunction in neuropsychiatric disorders: Implications for therapeutic intervention
Duarte-Silva, E. P., Maes, M. H. J., & Peixoto, C. A. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115343 · Cited by 10
Attenuated initial serum ferritin concentration in critically ill coronavirus disease 2019 geriatric patients with comorbid psychiatric conditions
Abulseoud, O. A., Yehia, A., Egol, C., Nettey, V. N., Aly, M. H., Qu, Y., Skolnik, A. B., Grill, M. F., Sen, A., & Schneekloth, T. D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1035986 · Cited by 8
Thyroid dysfunction in young, first-episode and drug-naïve patients with major depressive disorder: prevalence and associated clinical factors
Wu, J., Wang, Z., Xu, H., Yang, L., Liu, J., Zheng, Y., Kang, C., Wang, X., Shi, J., Zhao, N., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1156481 · Cited by 8
Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis
Woo, H. I., Park, J., Lim, S., Kim, D. K., & Lee, S. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02702-y · Cited by 8
Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers
Giusti, L., Ciregia, F., Mazzoni, M. R., & Lucacchini, A. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1230499 · Cited by 8
Depression, family and immunity: influence of humoral immunity on family relationships and on the severity of depression.
Tomasović, S., Sremec, J., Košćak, J., Klepac, N., Draganić, P., & Bielen, I. (2016) · PubMed · Cited by 6
Effect of "Tiaoshen" acupuncture technique on mild depression and its underlying mechanism: A randomized controlled trial study protocol
Bai, L., Zou, W., Wang, L., Yu, X., Lou, H., Dai, X., Teng, W., Yu, W., Li, M., Cao, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28889 · Cited by 5
Association Between the C4 Binding Protein Level and White Matter Integrity in Major Depressive Disorder
Park, J., Kang, Y., Han, K., Tae, W., Kang, U., Chu, H., & Ham, B. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0100 · Cited by 4
Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder
Supti, K. F., Asaduzzaman, M., Suhee, F. I., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., Qusar, M. S., & Islam, M. R. (2023) · Clinical Pathology · doi:10.1177/2632010x231220841 · Cited by 4
Distinct behavioural and neurovascular signatures induced by acute and chronic stress in rats
Simões, D. M., Carreira, J., Henriques, A., Gaspar, R., Sanches, E. S., Baptista, F. I., & Silva, A. P. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115706 · Cited by 4
Towards Objective Major Depressive Disorder Detection: a Systematic Review and Meta-Analysis of Diagnostic Biomarkers
Gulbaz, Z.-U.-A., Mirza, S., Naveed, S., Azeem, M. W., Husain, N., & Cheema, M. I. (2025) · Psychiatric Quarterly · doi:10.1007/s11126-025-10223-w · Cited by 2
Proteomic Studies of Psychiatric Disorders
Guest, P. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7614-0_4 · Cited by 2
Aging, Cerebrovascular Burden, and Cognitive Decline
Cho, K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89854 · Cited by 3
LC-MSE for Qualitative and Quantitative Proteomic Studies of Psychiatric Disorders
Fioramonte, M., Guest, P. C., & Martins‐de‐Souza, D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-52479-5_7 · Cited by 2
Integrating Forensic Autopsies with Proteomic Profiling for Suicide Risk Assessment: A Comprehensive Review of Literature
Al-Habash, I. H., Alshaeb, A., Srpanova, V. B., Alempijevic, D. M., Marković, M. K., Concato, M., Radaelli, D., & D’Errico, S. (2025) · Current Neuropharmacology · doi:10.2174/011570159x344453241129073214 · Cited by 1
Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor
Brösecke, F., Pfau, A. C., Ermer, T., Ribeiro, A. B. D. T. M., Rubenbauer, L., Rao, V., Burlein, S., Genser, B., Reichel, M., Aronson, P. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61808-7 · Cited by 1
Central and peripheral molecular profiling of sex differences in schizophrenia, major depressive disorder, and controls
Ramsey, J. M. (2015) · Apollo (University of Cambridge) · doi:10.17863/cam.268
Investigating neurobiological mechanisms linking depression and inflammation
Hasebe, K. (2017) · Figshare

Authors: Stelzhammer, V., Haenisch, F., Chan, M. K., Cooper, J. D., Steiner, J., Steeb, H., Martins-de-Souza, D., Rahmoune, H., Guest, P. C., & Bahn, S.
Affiliations: University of Cambridge (GB)
Corresponding author: Bahn, Sabine
ORCID: Haenisch, Frieder
Chan, Man K.
Cooper, Jason D.
Martins-de-Souza, Daniel
Guest, Paul C.
Bahn, Sabine
Venue: The International Journal of Neuropsychopharmacology
Publisher: Oxford University Press (OUP)
Published: 2014-06-05
Volume: 17
Issue: 10
Pages: 1599-1608
ISSN: 1461-1457 (ISSN-L)
1469-5111
DOI: 10.1017/s1461145714000819
OpenAlex: W2117492847
Cited by: 105
References: 45
Citations by year: 2025: 4 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 13 · 2020: 8 · 2019: 5 · 2018: 9 · 2017: 14 · 2016: 19 · 2015: 10 · 2014: 1
FWCI: 10.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The International Journal of Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Americanae (AECID Library) (submittedVersion, other-oa)
Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords: major depressive disorder, first-episode depression, serum proteomics, biomarkers, symptom severity, inflammation, oxidative stress, hypothalamic-pituitary-adrenal axis, cortisol, cytokines, macrophage migration inhibitory factor, interleukin-16, angiotensin-converting enzyme, ferritin, brain-derived neurotrophic factor, complement C4B, growth hormone, superoxide dismutase 1
MeSH terms: Adult, Analysis of Variance, Blood Proteins, Chromatography, Liquid, Complement System Proteins, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Hydrocortisone, Immunoassay, Peptidyl-Dipeptidase A, Male, Middle Aged, Psychiatric Status Rating Scales, Mass Spectrometry, Statistics as Topic, Case-Control Studies, Cytokines, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks